GLP 1 and obesity stocks
Heavily traded in GLP 1 and obesity
Turnover over $10M/day9 of about 30 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Sep 15, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| LLYEli Lilly and Company | $2.88B | +52.88% | Oct 29, 2026 |
| NVONovo Nordisk A/S | $430.22M | −19.02% | Nov 4, 2026 |
| MDGLMadrigal Pharmaceuticals, Inc. | $152.12M | +26.89% | Nov 4, 2026 |
| 128940.KSHanmi Pharm. Co., Ltd. | $47.42B | +58.26% | Oct 29, 2026 |
| VKTXViking Therapeutics, Inc. | $59.25M | +30.91% | Oct 28, 2026 |
| MBXMBX Biosciences, Inc. | $32.72M | +447.29% | Nov 5, 2026 |
| GPCRStructure Therapeutics Inc. | $23.68M | +90.30% | Nov 5, 2026 |
| 008930.KSHanmi Science Co., Ltd. | $10.42B | +30.27% | — |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
31 companies, largest market value first.
Data as of Sep 15, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.01T | Mega cap | +52.88% |
| NVO | Novo Nordisk A/S | $192.00B | Large cap | −19.02% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.48B | Large cap | +26.89% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.39B | Mid cap | +58.26% |
| VKTX | Viking Therapeutics, Inc. | $3.68B | Mid cap | +30.91% |
| MBX | MBX Biosciences, Inc. | $2.87B | Mid cap | +447.29% |
| GPCR | Structure Therapeutics Inc. | $2.74B | Mid cap | +90.30% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.57B | Mid cap | +30.27% |
| KLRA | Kailera Therapeutics, Inc. | $1.78B | Small cap | −47.12% |
| IVA.PA | Inventiva S.A. | $928.68M | Small cap | −22.90% |
| IVA | Inventiva S.A. | $916.54M | Small cap | −26.93% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $881.01M | Small cap | +76.79% |
| ALT | Altimmune, Inc. | $641.91M | Small cap | −8.08% |
| ENTX | Entera Bio Ltd. | $488.26M | Small cap | +54.10% |
| WW | WW International, Inc. | $152.28M | Small cap | −45.97% |
| MED | Medifast, Inc. | $134.17M | Small cap | −15.61% |
| RANI | Rani Therapeutics Holdings, Inc. | $117.45M | Small cap | +71.31% |
| VANI | Vivani Medical, Inc. | $113.66M | Small cap | −0.79% |
| GUTS | Fractyl Health, Inc. | $97.35M | Micro cap | −37.68% |
| IBIO | iBio, Inc. | $59.61M | Micro cap | +34.83% |
| ALGS | Aligos Therapeutics, Inc. | $31.47M | Micro cap | −46.21% |
| ALVAL.PA | Valbiotis SA | $30.94M | Micro cap | −9.30% |
| PTN | Palatin Technologies, Inc. | $23.77M | Micro cap | +58.29% |
| ASBP | Aspire Biopharma Holdings, Inc. | $12.43M | Micro cap | −46.24% |
| MTVA | MetaVia Inc. | $10.67M | Micro cap | −90.18% |
| OPTI.L | OptiBiotix Health Plc | $8.85M | Micro cap | −36.50% |
| SKYE | Skye Bioscience, Inc. | $8.81M | Micro cap | −51.11% |
| LEXX | Lexaria Bioscience Corp. | $7.48M | Micro cap | +173.08% |
| TCRT | Alaunos Therapeutics, Inc. | $3.79M | Micro cap | −33.78% |
| ELAB | PMGC Holdings Inc. | $3.74M | Micro cap | −96.66% |
| VERU | Veru Inc. | — | — | −33.90% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 31 companies grouped under the GLP 1 and obesity theme. The median market value in the group is $143.22M. Across the group, the median move over the past trading day is −0.83%. 40% of the 30 with a 200-day average trade above it. Price change over the past year runs from −47.1% to +76.8% across the middle 80 percent of the group, with a median of −9.3%.